Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
Teva
Harvard Business School
AstraZeneca
Chinese Patent Office
Fuji
Cipla
Cerilliant
Julphar

Generated: December 11, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019721

« Back to Dashboard

NDA 019721 describes NORDITROPIN, which is a drug marketed by Novo Nordisk Inc and is included in two NDAs. It is available from two suppliers. There are sixteen patents protecting this drug. Additional details are available on the NORDITROPIN profile page.

The generic ingredient in NORDITROPIN is somatropin recombinant. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the somatropin recombinant profile page.

Summary for 019721

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength4MG/VIAL
Approval Date:May 8, 1995TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength8MG/VIAL
Approval Date:May 8, 1995TE:RLD:No

Expired Orange Book Patents for NDA: 019721

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novo Nordisk IncNORDITROPINsomatropin recombinantINJECTABLE;INJECTION019721-001May 8, 1995► Subscribe► Subscribe
Novo Nordisk IncNORDITROPINsomatropin recombinantINJECTABLE;INJECTION019721-002May 8, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Express Scripts
Chinese Patent Office
McKinsey
Fish and Richardson
Merck
McKesson
Deloitte
Healthtrust
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot